Cargando…
Gazing Long into a Clinical and Social Abyss? Treating Hypertrophic Scarring and Keloids
This commentary discusses the unmet clinical and social needs associated with hypertrophic scars and keloids. The authors critically appraise these issues within the context of contemporary clinical standards of care and social mores catalyzed by the COVID-19 pandemic.
Autores principales: | Carter, Alison R., Davies, Benjamin M., Brindley, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403195/ https://www.ncbi.nlm.nih.gov/pubmed/34155931 http://dx.doi.org/10.1089/rej.2021.0037 |
Ejemplares similares
-
The combined application of bleomycin and triamcinolone for the treatment of keloids and hypertrophic scars: An effective therapy for treating refractory keloids and hypertrophic scars
por: Luo, Quan‐Feng
Publicado: (2023) -
The Roles of Inflammation in Keloid and Hypertrophic Scars
por: Wang, Zheng-Cai, et al.
Publicado: (2020) -
Osteopathic Approach for Keloids and Hypertrophic Scars
por: Bordoni, Bruno, et al.
Publicado: (2023) -
Keloids and Hypertrophic Scars: Update and Future Directions
por: Huang, Chenyu, et al.
Publicado: (2013) -
Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids
por: Pavelecini, Michel, et al.
Publicado: (2019)